רנקסה 1000 מ"ג
País: Israel
Idioma: hebreu
Font: Ministry of Health
Alguns documents d’aquest producte actualment no estan disponibles, podeu enviar una sol·licitud al nostre servei d’atenció al client i us ho notificarem tan bon punt puguem obtenir-los.
Enviar sol.licitud.
Enviar sol.licitud.
ingredients actius:
RANOLAZINE 1000 MG
Disponible des:
NEOPHARM LTD
Codi ATC:
C01EB18
formulario farmacéutico:
TABLETS EXTENDED RELEASE
Vía de administración:
PER OS
Fabricat per:
CV THERAPEUTICS INC, USA
Grupo terapéutico:
RANOLAZINE
indicaciones terapéuticas:
Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Data d'autorització:
2010-10-01
